393
Views
54
CrossRef citations to date
0
Altmetric
Articles

Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients

, , , , &
Pages 422-427 | Accepted 29 Apr 2011, Published online: 11 Dec 2011
 

Abstract

Objective: To determine whether the presence of anti-cyclic citrullinated peptide (anti-CCP) antibodies and rheumatoid factor immunoglobulin M (RF IgM) is associated with endothelial dysfunction in patients with rheumatoid arthritis (RA).

Methods: We studied the presence of anti-CCP antibodies and RF IgM and endothelial function in terms of the reactive hyperaemic index (RHI) in 53 consecutive RA patients. Endothelial function was measured by using a finger plethysmograph.

Results: RHI was significantly lower in anti-CCP-positive RA patients (n  =  33, RHI  =  1.78, SD  =  0.30) than in anti-CCP-negative RA patients (n  =  20, RHI  =  2.19, SD = 0.59; p  =  0.008). A similar result was found in RF IgM-positive patients (n  =  34, RHI  =  1.77, SD  =  0.30) vs. RF IgM-negative patients (n  =  19, RHI  =  2.23, SD  =  0.58; p  =  0.003). There were no significant differences between the groups regarding age, gender, traditional cardiovascular risk markers, Disease Activity Score using 28 joint counts (DAS28), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), extra-articular manifestations (EAMs), use of glucocorticosteroids, statins, angiotensin-converting enzyme (ACE) inhibitors, and non-steroidal anti-inflammatory drugs (NSAIDs).

Conclusion: The presence of anti-CCP antibodies and RF IgM was related to impaired endothelial function independent of other cardiovascular risk factors in RA patients. Thus, these autoantibodies might reflect an early reversible stage of the atherosclerotic process, and may indicate increased risk of cardiovascular disease (CVD). Further studies are needed to explore whether anti-CCP antibodies and RF IgM may act directly or indirectly to cause endothelial dysfunction, or merely reflect endothelial dysfunction in RA patients.

Acknowledgements

This work was supported by Abbott Medical.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.